Last checked at 20 Jul 2021 14:34
Ap19
FORM 8.3 - Amendment to Purchases & Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | AON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 16 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
652,435 | 0.29% | 1,658,404 | 0.73% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
180,976 | 0.08% | 0 | 0.00% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 24,200 | 0.01% | 24,200 | 0.01% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
857,611 | 0.38% | 1,682,604 | 0.75% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase | 4 | 230.7300 USD |
Purchase | 6 | 230.8100 USD |
Purchase | 8 | 231.0350 USD |
Purchase | 8 | 230.6750 USD |
Purchase | 18 | 231.2850 USD |
Purchase | 21 | 231.0471 USD |
Purchase | 23 | 231.3700 USD |
Purchase | 27 | 231.1544 USD |
Purchase | 63 | 231.3047 USD |
Purchase | 81 | 231.7100 USD |
Purchase | 100 | 230.9700 USD |
Purchase | 100 | 232.1600 USD |
Purchase | 100 | 231.8400 USD |
Purchase | 100 | 231.6850 USD |
Purchase | 100 | 231.6350 USD |
Purchase | 100 | 231.5500 USD |
Purchase | 100 | 231.1900 USD |
Purchase | 101 | 232.2612 USD |
Purchase | 101 | 231.7800 USD |
Purchase | 133 | 231.4071 USD |
Purchase | 153 | 231.1530 USD |
Purchase | 192 | 231.7178 USD |
Purchase | 200 | 231.1200 USD |
Purchase | 200 | 230.8050 USD |
Purchase | 200 | 231.4275 USD |
Purchase | 200 | 231.2750 USD |
Purchase | 200 | 230.8742 USD |
Purchase | 202 | 231.2589 USD |
Purchase | 218 | 231.7306 USD |
Purchase | 239 | 231.9430 USD |
Purchase | 250 | 230.9956 USD |
Purchase | 253 | 231.6738 USD |
Purchase | 300 | 231.9316 USD |
Purchase | 300 | 231.1333 USD |
Purchase | 412 | 231.7681 USD |
Purchase | 490 | 231.5695 USD |
Purchase | 500 | 231.9500 USD |
Purchase | 725 | 231.8541 USD |
Purchase | 755 | 231.4161 USD |
Purchase | 955 | 231.4843 USD |
Purchase | 979 | 231.6625 USD |
Purchase | 1,100 | 231.4654 USD |
Purchase | 1,251 | 231.6780 USD |
Purchase | 1,284 | 231.4742 USD |
Purchase | 2,100 | 231.4944 USD |
Purchase | 3,698 | 231.4781 USD |
Purchase | 4,230 | 231.4013 USD |
Purchase | 5,190 | 231.6357 USD |
Purchase | 5,225 | 231.7635 USD |
Purchase | 5,358 | 231.7598 USD |
Purchase | 7,237 | 231.3501 USD |
Purchase | 7,431 | 231.4876 USD |
Purchase | 10,752 | 231.6749 USD |
Purchase | 10,800 | 230.9405 USD |
Purchase | 20,624 | 231.7260 USD |
Purchase | 23,000 | 220.0000 USD |
Purchase | 27,590 | 231.7300 USD |
Purchase | 38,654 | 231.5544 USD |
Sale | 3 | 230.6300 USD |
Sale | 7 | 231.5642 USD |
Sale | 12 | 231.2400 USD |
Sale | 17 | 232.0600 USD |
Sale | 27 | 231.6300 USD |
Sale | 39 | 231.7061 USD |
Sale | 40 | 231.4837 USD |
Sale | 42 | 231.8935 USD |
Sale | 48 | 231.8162 USD |
Sale | 51 | 231.3200 USD |
Sale | 61 | 231.1232 USD |
Sale | 77 | 231.6500 USD |
Sale | 79 | 231.6667 USD |
Sale | 100 | 232.2100 USD |
Sale | 100 | 231.8400 USD |
Sale | 100 | 231.2500 USD |
Sale | 100 | 230.5350 USD |
Sale | 100 | 232.1600 USD |
Sale | 100 | 231.6850 USD |
Sale | 101 | 232.2285 USD |
Sale | 108 | 231.0288 USD |
Sale | 111 | 231.5637 USD |
Sale | 111 | 231.7005 USD |
Sale | 112 | 231.2689 USD |
Sale | 122 | 231.3478 USD |
Sale | 136 | 230.7075 USD |
Sale | 143 | 231.6701 USD |
Sale | 147 | 231.6977 USD |
Sale | 150 | 230.9933 USD |
Sale | 185 | 231.6091 USD |
Sale | 200 | 231.3950 USD |
Sale | 218 | 231.7306 USD |
Sale | 253 | 231.3132 USD |
Sale | 271 | 231.6467 USD |
Sale | 299 | 231.4814 USD |
Sale | 300 | 231.6333 USD |
Sale | 300 | 231.9466 USD |
Sale | 301 | 231.0383 USD |
Sale | 378 | 231.1158 USD |
Sale | 400 | 231.5925 USD |
Sale | 400 | 231.7200 USD |
Sale | 408 | 230.7462 USD |
Sale | 416 | 231.0554 USD |
Sale | 450 | 230.9416 USD |
Sale | 500 | 231.3540 USD |
Sale | 602 | 230.8828 USD |
Sale | 751 | 231.7731 USD |
Sale | 806 | 231.7800 USD |
Sale | 940 | 231.5548 USD |
Sale | 1,000 | 231.6008 USD |
Sale | 1,069 | 232.1204 USD |
Sale | 1,166 | 230.9709 USD |
Sale | 1,256 | 231.3192 USD |
Sale | 1,454 | 231.3921 USD |
Sale | 2,227 | 231.1322 USD |
Sale | 2,252 | 231.4167 USD |
Sale | 2,839 | 231.5799 USD |
Sale | 4,255 | 231.5190 USD |
Sale | 4,731 | 231.7037 USD |
Sale | 5,172 | 231.3899 USD |
Sale | 5,399 | 231.7536 USD |
Sale | 6,085 | 231.2755 USD |
Sale | 6,178 | 231.5123 USD |
Sale | 7,269 | 230.9242 USD |
Sale | 8,183 | 231.7288 USD |
Sale | 17,451 | 231.6102 USD |
Sale | 22,884 | 231.7300 USD |
Sale | 30,695 | 231.6078 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | YES |
| Date of disclosure: | 20 Jul 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
| Product name | Written or | Number of | Exercise | Type | Expiry |
| purchased | relevant securities | price | date | ||
| to which the option | |||||
| or derivative | |||||
| relates | |||||
Put Options | Purchased | -1,200 | 220.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 1,200 | 240.0000 | American | Jul 16, 2021 |
Call Options | Purchased | 23,000 | 220.0000 | American | Jul 16, 2021 |
Put Options | Purchased | -23,000 | 200.0000 | American | Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210720005802/en/
Copyright Business Wire 2021